Arca Biopharma | ABIO - Gross Profit On Sales


Arca Biopharma reported 0 in Gross Profit on Sales for its fiscal quarter ending in March of 2025.





Gross Profit On Sales Change Date
Amgen USD 5.87B 1.02B Mar/2026
Arca Biopharma 0 0 Mar/2025
Biogen USD 2.12B 307M Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cipla INR 44.1B 5B Jun/2026
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 352K 63.44M Mar/2026
CSL USD 4.46B 2.71B Dec/2025
Cytokinetics USD 23.03M 3.84M Jun/2026
Daiichi Sankyo JPY 287.15B 152.68B Mar/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Grifols EUR 766.49M 39.74M Dec/2024
Laboratory Of America USD 1.11B 98.2M Jun/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Otsuka Holdings JPY 456.25B 1.16B Mar/2026
Pfizer USD -248M 11.29B Jun/2026
United Therapeutics USD 683.8M 35.7M Jun/2026